The perfect home for your antibody research
Antibody Therapeutics provides the ideal outlet for your research on the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Antibody Therapeutics is indexed in the Web of Science. Submit now and enjoy a 50% APC discount through 31 December 2025.
Learn more about why the journal is the perfect home for your researchMore from Antibody Therapeutics
Accepted for indexing in ESCI
Antibody Therapeutics has been accepted by Clarivate for indexing in the Emerging Sources Citation Index (ESCI). This means that all content published in the Journal will now be indexed in Web of Science, providing greater discoverability and dissemination of content for published authors.
Explore more author benefits
Special Collections
Explore special collections from Antibody Therapeutics highlighting the latest research on important topics in the field.
- AntibodyPlus™: Therapeutics comprising antibody and effector modules
- Antibody-targeted Cytotoxic agents – Immunotoxins and ADCs
- Bispecific Antibody CMC
Browse the special collections
Calls for Papers
Antibody Therapeutics is currently seeking submissions for the following special issues:- Formulation of Antibody-Based Therapeutics | Submission deadline: 31 December 2024
- Antibody-Drug Conjugates for Cancer Treatment | Submission deadline: 31 December 2024
- Cell Therapies and Cell Engagers against Cancer | Submission deadline: 30 June 2025
High-Impact Research Collection
Explore a collection of the most read, most cited, and most discussed articles published in Antibody Therapeutics in recent years. Discover what has caught the attention of your peers.
Browse the collection
Publish open access at a discounted cost
Submit your research to Antibody Therapeutics and receive 50% off the Article Processing Charge. Benefit from open access, which ensures greater visibility, increased citations, and enhanced impact. This offer is valid until 31 December 2025.
Learn more about publishing with us
Never miss the latest research
As a dedicated researcher or enthusiast in the field of antibody therapeutics, you won't want to miss out on the latest breakthroughs and discoveries.
Learn more & sign up for email alerts
More from CAS
About the society
Antibody Therapeutics is the official journal of the Chinese Antibody Society (CAS). The mission of CAS is to bring together industry leaders, healthcare providers, researchers, academics, and investors to connect and collaborate on the discover, development, manufacturing, and marketing of therapeutic antibodies.
Learn more
Become a member
Chinese Antibody Society membership comes with a host of benefits including networking opportunities, access to the society's exclusive WeChat group, discounted meeting registration fees, and educational webinars.
Join today
CAS Career Center
Visit the Chinese Antibody Society's career center where you can search featured jobs and employers in popular fields within antibody therapeutics such as jobs within project management, research and development, or business development.
Visit now
